Edwards Lifesciences Pre-Tax Profit Margin 2010-2025 | EW
Current and historical pre-tax profit margin for Edwards Lifesciences (EW) from 2010 to 2025. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue. Edwards Lifesciences pre-tax profit margin for the three months ending March 31, 2025 was .
| Edwards Lifesciences Pre-Tax Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Pre-Tax Income | Pre-Tax Margin |
| 2025-03-31 | $5.52B | $1.61B | 29.19% |
| 2024-12-31 | $5.44B | $1.55B | 28.48% |
| 2024-09-30 | $5.08B | $1.47B | 28.96% |
| 2024-06-30 | $4.97B | $1.46B | 29.31% |
| 2024-03-31 | $4.88B | $1.35B | 27.56% |
| 2023-12-31 | $5.01B | $1.37B | 27.40% |
| 2023-09-30 | $4.43B | $1.27B | 28.74% |
| 2023-06-30 | $4.51B | $1.29B | 28.68% |
| 2023-03-31 | $4.58B | $1.48B | 32.34% |
| 2022-12-31 | $4.46B | $1.52B | 34.03% |
| 2022-09-30 | $5.36B | $1.68B | 31.39% |
| 2022-06-30 | $5.36B | $1.67B | 31.15% |
| 2022-03-31 | $5.36B | $1.75B | 32.65% |
| 2021-12-31 | $5.23B | $1.70B | 32.52% |
| 2021-09-30 | $5.10B | $1.68B | 33.01% |
| 2021-06-30 | $4.93B | $1.66B | 33.60% |
| 2021-03-31 | $4.48B | $0.94B | 21.03% |
| 2020-12-31 | $4.39B | $0.92B | 20.90% |
| 2020-09-30 | $4.37B | $0.88B | 20.07% |
| 2020-06-30 | $4.32B | $0.82B | 18.86% |
| 2020-03-31 | $4.48B | $1.25B | 27.97% |
| 2019-12-31 | $4.35B | $1.17B | 26.84% |
| 2019-09-30 | $4.15B | $0.85B | 20.45% |
| 2019-06-30 | $3.97B | $0.80B | 20.08% |
| 2019-03-31 | $3.82B | $0.78B | 20.30% |
| 2018-12-31 | $3.72B | $0.76B | 20.46% |
| 2018-09-30 | $3.64B | $1.09B | 29.93% |
| 2018-06-30 | $3.55B | $1.05B | 29.61% |
| 2018-03-31 | $3.45B | $1.01B | 29.18% |
| 2017-12-31 | $3.44B | $1.04B | 30.14% |
| 2017-09-30 | $3.32B | $0.91B | 27.50% |
| 2017-06-30 | $3.23B | $0.89B | 27.37% |
| 2017-03-31 | $3.15B | $0.85B | 26.92% |
| 2016-12-31 | $2.96B | $0.74B | 24.87% |
| 2016-09-30 | $2.87B | $0.70B | 24.56% |
| 2016-06-30 | $2.74B | $0.67B | 24.43% |
| 2016-03-31 | $2.60B | $0.64B | 24.72% |
| 2015-12-31 | $2.49B | $0.62B | 24.98% |
| 2015-09-30 | $2.44B | $0.59B | 24.13% |
| 2015-06-30 | $2.43B | $0.56B | 22.99% |
| 2015-03-31 | $2.39B | $1.23B | 51.46% |
| 2014-12-31 | $2.32B | $1.14B | 49.27% |
| 2014-09-30 | $2.24B | $1.11B | 49.60% |
| 2014-06-30 | $2.13B | $1.09B | 51.20% |
| 2014-03-31 | $2.07B | $0.40B | 19.22% |
| 2013-12-31 | $2.05B | $0.51B | 25.02% |
| 2013-09-30 | $2.02B | $0.53B | 26.29% |
| 2013-06-30 | $1.97B | $0.52B | 26.57% |
| 2013-03-31 | $1.94B | $0.49B | 25.45% |
| 2012-12-31 | $1.90B | $0.39B | 20.43% |
| 2012-09-30 | $1.82B | $0.34B | 18.58% |
| 2012-06-30 | $1.78B | $0.30B | 16.98% |
| 2012-03-31 | $1.73B | $0.29B | 16.50% |
| 2011-12-31 | $1.68B | $0.29B | 16.97% |
| 2011-09-30 | $1.64B | $0.29B | 17.43% |
| 2011-06-30 | $1.58B | $0.29B | 18.64% |
| 2011-03-31 | $1.51B | $0.29B | 18.99% |
| 2010-12-31 | $1.45B | $0.27B | 18.52% |
| 2010-09-30 | $1.40B | $0.26B | 18.54% |
| 2010-06-30 | $1.38B | $0.29B | 20.88% |
| 2010-03-31 | $1.35B | $0.29B | 21.11% |
| 2009-12-31 | $1.32B | $0.30B | 22.98% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $45.778B | $5.440B |
| Edwards Lifesciences Corporation deals in products and technologies aimed at treating advanced cardiovascular diseases, especially structural heart disease in critically ill patients. The company is the world's leading manufacturer of tissue heart valves and repair products used to replace or repair a patient's diseased or defective heart valve. Edwards is also a leading player in hemodynamic monitoring systems used to measure a patient's cardiovascular function in the hospital setting. The company's products and technologies are categorized into four main areas: Transcatheter Aortic Valve Replacement (TAVR), Transcatheter Mitral and Tricuspid Therapies (TMTT), Surgical Structural Heart, and Critical Care. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $201.298B | 88.17 |
| Thermo Fisher Scientific (TMO) | United States | $156.252B | 18.90 |
| Alcon (ALC) | Switzerland | $44.076B | 29.79 |
| IDEXX Laboratories (IDXX) | United States | $41.955B | 48.21 |
| DexCom (DXCM) | United States | $34.098B | 52.70 |
| IQVIA Holdings (IQV) | United States | $24.832B | 13.91 |
| STERIS (STE) | Ireland | $24.813B | 27.36 |
| Mettler-Toledo (MTD) | United States | $24.089B | 28.65 |
| Waters (WAT) | United States | $21.336B | 30.10 |
| SONOVA HOLDING (SONVY) | Switzerland | $20.297B | 0.00 |
| Hologic (HOLX) | United States | $12.575B | 13.66 |
| Penumbra (PEN) | United States | $10.904B | 85.58 |
| Sysmex ADR (SSMXY) | Japan | $10.525B | 29.86 |
| Masimo (MASI) | United States | $8.411B | 31.03 |
| Globus Medical (GMED) | United States | $8.397B | 19.69 |
| Teleflex (TFX) | United States | $5.662B | 9.35 |
| Glaukos (GKOS) | United States | $5.477B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.238B | 22.20 |
| TransMedics (TMDX) | United States | $4.130B | 89.78 |
| PROCEPT BioRobotics (PRCT) | United States | $3.280B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.398B | 14.28 |
| Veracyte (VCYT) | United States | $2.271B | 31.87 |
| Nihon Kohden (NHNKY) | Japan | $2.119B | 24.30 |
| Elekta AB (EKTAY) | Sweden | $2.079B | 18.69 |
| Alphatec Holdings (ATEC) | United States | $1.905B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.514B | 0.00 |
| Artivion (AORT) | United States | $1.269B | 118.84 |
| Pulse Biosciences (PLSE) | United States | $1.152B | 0.00 |
| OPKO Health (OPK) | United States | $1.055B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.053B | 5.60 |
| SiBone (SIBN) | United States | $0.829B | 0.00 |
| IRadimed (IRMD) | United States | $0.689B | 34.97 |
| RxSight (RXST) | United States | $0.663B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.655B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.644B | 14.08 |
| Delcath Systems (DCTH) | United States | $0.630B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.601B | 9.35 |
| NeuroPace (NPCE) | United States | $0.558B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.557B | 0.00 |
| AxoGen (AXGN) | United States | $0.536B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.483B | 12.84 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.471B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.423B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.389B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.367B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.306B | 0.00 |
| Neuronetics (STIM) | United States | $0.282B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.242B | 14.65 |
| Alpha Tau Medical (DRTS) | Israel | $0.218B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.184B | 0.00 |
| CVRx (CVRX) | United States | $0.179B | 0.00 |
| 908 Devices (MASS) | United States | $0.171B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.169B | 0.00 |
| Accuray (ARAY) | United States | $0.167B | 0.00 |
| LENSAR (LNSR) | United States | $0.166B | 0.00 |
| Inogen (INGN) | United States | $0.165B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.145B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.144B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.137B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.136B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.127B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.100B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.096B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.078B | 47.30 |
| EDAP TMS S.A (EDAP) | France | $0.070B | 0.00 |
| InspireMD (NSPR) | Israel | $0.069B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.069B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.064B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.051B | 15.50 |
| Hyperfine (HYPR) | United States | $0.049B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.045B | 0.00 |
| Envoy Medical (COCH) | United States | $0.036B | 0.00 |
| Precision Optics (POCI) | United States | $0.034B | 0.00 |
| Spectral AI (MDAI) | United States | $0.034B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.034B | 0.00 | |
| DarioHealth (DRIO) | United States | $0.029B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.019B | 0.00 |
| NexGel (NXGL) | United States | $0.018B | 0.00 |
| PAVmed (PAVM) | United States | $0.011B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.010B | 0.00 |
| Tenon Medical (TNON) | United States | $0.009B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.008B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.007B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.006B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.005B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.005B | 0.00 |
| Nuwellis (NUWE) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.001B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.001B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 16.66 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |